JNJ Beat Earnings | January 26

by Luna Fuller
0 comment

Good Evening!

The DJIA fell 0.03%
The S&P 500 was down 0.03%
The Nasdaq Composite slipped 0.13%

Industrials and pharmaceuticals led the market today.

General Market Review


Investors are focused on monetary policy as the Fed is expected to deliver a balanced outlook on the economy. The Fed is forecast to keep rates the same through 2023. While a faster pace of inflation is expected post-Covid, the Fed will likely not taper bond purchases.


While General Electric missed expectations on earnings, it beat revenue and reported better-than-expected free cash flows. GE was up about 2% today. Boeing is set to release a quarterly report early tomorrow.


Johnson & Johnson reported positive earnings today with an EPS of $1.86 and revenue of $22.48 billion. These earnings compare to investor expectations of $1.82 for EPS and $21.67 for revenue. Analysts are anticipating the authorization of the J&J vaccine by as early as next month. This vaccine would only be a single dose. JNJ gained close to 3%.

You may also like